New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
No clinically approved therapies are currently available that prevent the onset of photoreceptor death in retinal degeneration. Signaling between retinal neurons is regulatedby the release and uptake of neurotransmitters, wherein GABA is the main inhibitory neurotransmitter. In this work, novel 3‐chloropropiophenone derivatives and the clinical anticonvulsants tiagabine and vigabatrin were tested to modulate GABA signaling and protect against light‐induced retinal degeneration. Abca4 −/− Rdh8 −/− mice, an accelerated model of retinal degeneration, were exposed to intense light after prophylactic injections of one of these compounds. Imaging and functional assessments of the retina indicated that these compounds successfully protected photoreceptor cells from degeneration to maintain a full‐visual‐field response. Furthermore, these compounds demonstrated a strong safety profile in wild‐type mice and did not compromise visual function or damage the retina, despite repeated administration. These results indicate that modulating inhibitory GABA signaling can offer prophylactic protection against light‐induced retinal degeneration.—Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., Lu, Z.‐R. New GABA modulators protect photoreceptor cells from light‐induced degeneration in mouse models. FASEB J. 32, 3289–3300 (2018). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure of the retina to excessive light (i.e., 10,000 lux for 30–60 min in a photosensitive Abca4 −/− Rdh8 −/− mouse model) causes photoreceptor cell death, retinal inflammation and other degenerative changes [ 63 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [63]
Citations
Cites
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Mattapallil, M. J., Wawrousek, E. F., Chan, C.-C., Zhao, H., Roychoudhury, J., Ferguson, T. A., & Caspi, R. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9662 · Cited by 678
Wenzel, A., Grimm, C., Samardzija, M., & Remé, C. E. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.08.002 · Cited by 644
Oxidative Damage and Age Related Macular Degeneration
Renganathan, K. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 566
(1999) · PubMed · Cited by 539
Research works printed but not linked: 1
- 10.1002/(SICI)1096-9861(19971110)388:1<1::AID-CNE1>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19971110)388:1<1::aid-cne1>3.0.co;2-5
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Rôżanowska, M. (2023) · Antioxidants · doi:10.3390/antiox12122111 · Cited by 65
Carullo, G., Federico, S., Relitti, N., Gemma, S., Butini, S., & Campiani, G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00358 · Cited by 33
Telegina, D. V., Antonenko, A. K., Фурсова, А. Ж., & Kolosova, N. G. (2022) · Biogerontology · doi:10.1007/s10522-022-09983-w · Cited by 23
“Nowadays, there is some information about deviations in neurotransmitter systems in the retina in AMD (George et al. 2018; Schur et al. 2018).”
BackgroundBoff, J. M., Shrestha, A. P., Madireddy, S., Viswaprakash, N., Santina, L. D., & Vaithianathan, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042226 · Cited by 20
“Recent investigations involve the use of chloride derivatives as alternative therapeutics that maximize positive outcomes while minimizing irreversible side effects, thereby bypassing retinal risks [234].”
Background
Metadata
- Authors
- Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., & Lu, Z.-R.
- Affiliations
- Case Western Reserve University (US)
- Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering, Case Western Reserve University Cleveland Ohio USA
- Corresponding author
- Lu, Zheng-Rong
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-01-24
- Volume
- 32
- Issue
- 6
- Pages
- 3289-3300
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC5956245
- OpenAlex
- W2784969173
- Cited by
- 19
- References
- 75
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY027283, EY024864)
- National Institute of Biomedical Imaging and Bioengineering (T32EB007509)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Keywords
- photoreceptor degeneration, light-induced retinal degeneration, tiagabine, vigabatrin, antiepileptic drugs, ABCA4, neuroprotection, inhibitory neurotransmission, prophylaxis, visual function
- MeSH terms
- Alcohol Oxidoreductases, Animals, gamma-Aminobutyric Acid, Light, Propiophenones, Retinal Degeneration, Mice, Knockout, ATP-Binding Cassette Transporters, Photoreceptor Cells, Vertebrate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models. https://app.cochat.ai/papers/10.1096/fj.201701250r
- The paper
- Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., & Lu, Z.-R. (2018). New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models. The FASEB Journal. https://doi.org/10.1096/fj.201701250r
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.